These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7125430)

  • 1. Cholestyramine and probucol synergism.
    Nestel PJ
    Ann Intern Med; 1982 Oct; 97(4):622. PubMed ID: 7125430
    [No Abstract]   [Full Text] [Related]  

  • 2. Probucol with cholestyramine.
    Bateson MC
    Lancet; 1981 Jul; 2(8237):93. PubMed ID: 6113467
    [No Abstract]   [Full Text] [Related]  

  • 3. Probucol, cholestyramine, and serum cholesterol.
    Mann JI
    Lancet; 1981 Aug; 2(8243):422. PubMed ID: 6115188
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulation of cholesterol metabolism in Ehrlich ascites tumour cells by dietary cholesterol, cholestyramine and probucol.
    Esmail A; Fears R
    Biochem Soc Trans; 1980 Oct; 8(5):545. PubMed ID: 7450213
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effects of probucol and cholestyramine to lower serum cholesterol.
    Boyden TW; Totman L
    J Clin Pharmacol; 1981 Jan; 21(1):48-51. PubMed ID: 7217343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia.
    Pasquali R; Biso P; Parenti M; Melchionda N
    Lancet; 1981 Jun; 1(8234):1368. PubMed ID: 6113336
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
    Wissler RW; Vesselinovitch D
    Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probucol in patients resistant to the lipid-lowering effects of cholestyramine.
    Mann JI; Jelfs R; Cassels E; Barker K; Simpson HC; Carter RC
    Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diet and probucol.
    Rapado A; Castrillo JM; Díaz-Curiel M
    Arch Intern Med; 1979 Sep; 139(9):1062-3. PubMed ID: 475528
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of probucol on serum lipoprotein(a) levels.
    Maeda S; Okuno M; Abe A; Noma A
    Atherosclerosis; 1989 Oct; 79(2-3):267-9. PubMed ID: 2597236
    [No Abstract]   [Full Text] [Related]  

  • 13. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 15. Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucol.
    McNamara DJ; Bloch CA; Botha A; Mendelsohn D
    Biochim Biophys Acta; 1985 Mar; 833(3):412-6. PubMed ID: 3970963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol and the QT interval.
    McCaughan D
    Lancet; 1982 Jul; 2(8290):161. PubMed ID: 6123876
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of probucol on bile composition in man.
    Jirsa M; Marecek Z; Kerdac V; Kucerova L
    Artery; 1982; 10(1):44-7. PubMed ID: 7092575
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of probucol on cholesteryl ester transport.
    Chiesa G; Franceschini G; Sirtori CR
    Biochim Biophys Acta; 1990 Aug; 1045(3):302-4. PubMed ID: 2386803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of lipid-lowering drugs.
    LaRosa JC
    Angiology; 1982 Sep; 33(9):562-76. PubMed ID: 7125296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Probucol, HDL and inverse transport of cholesterol].
    Med Clin (Barc); 1989 Oct; 93(13):22-3 p.. PubMed ID: 2695695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.